
Royal Caribbean Cruises, Carnival, and Airbnb are the three Leisure stocks to watch today, according to MarketBeat’s stock screener tool. “Leisure stocks” are shares of companies that operate in the leisure and recreation industry, such as travel, hotels, cruise lines, casinos, restaurants, entertainment, and theme parks. For stock market investors, these companies are often considered cyclical investments because their earnings tend to rise when consumers have more disposable income and spend more on discretionary activities, and fall when the economy weakens. These companies had the highest dollar trading volume of any Leisure stocks within the last several days.
Royal Caribbean Cruises (RCL)
Royal Caribbean Cruises Ltd. operates as a cruise company worldwide. The company operates cruises under the Royal Caribbean International, Celebrity Cruises, and Silversea Cruises brands, which comprise a range of itineraries. As of February 21, 2024, it operated 65 ships. Royal Caribbean Cruises Ltd.
Carnival (CCL)
Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn.
Read Our Latest Research Report on CCL
Airbnb (ABNB)
Airbnb, Inc., together with its subsidiaries, operates a platform that enables hosts to offer stays and experiences to guests worldwide. The company’s marketplace connects hosts and guests online or through mobile devices to book spaces and experiences. It primarily offers private rooms, primary homes, and vacation homes.
Read Our Latest Research Report on ABNB
Featured Articles
- MarketBeat’s Top Five Stocks to Own in June 2026
- The Speed of Light: 5 Stocks Powering AI’s Optical Future
- Dollar General Signals Reversal With 60% Rebound Potential
- Kohl’s Stock Soars After Better-Than-Feared Quarter
- Credo Technologies Paved a Path to a $300 Price Point
- Eli Lilly Wins Back CVS Health, Reverting Novo’s Advantage
